CRSP logo

CRSP
CRISPR Therapeutics AG

41,727
Mkt Cap
$5.59B
Volume
1.8M
52W High
$78.48
52W Low
$33.03
PE Ratio
-8.90
CRSP Fundamentals
Price
$57.99
Prev Close
$55.72
Open
$57.35
50D MA
$51.94
Beta
1.54
Avg. Volume
2.26M
EPS (Annual)
-$6.47
P/B
2.89
$2,938.96
Loading...
Loading...
News
all
press releases
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) have received a consensus rating of "Moderate Buy" from the nineteen analysts that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell rating, six have given a hold rating, ten h...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $55.72, marking a -1.83% move from the previous day.
Zacks·3d ago
News Placeholder
Sumitomo Mitsui Trust Group Inc. Sells 205,564 Shares of CRISPR Therapeutics AG $CRSP
Sumitomo Mitsui Trust Group Inc. decreased its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) by 9.5% during the fourth quarter, according to the company in its most recent disclosure...
MarketBeat·5d ago
News Placeholder
CRISPR Therapeutics Touts Second Phase After Casgevy, Eyes 6 Data Readouts in 6 12 Months
CRISPR Therapeutics (NASDAQ:CRSP) CEO Sam Kulkarni told investors at the Needham Healthcare Conference that the company is moving into what he described as a second phase following the launch of...
MarketBeat·6d ago
News Placeholder
2 Billion Reasons to Love CRISPR Therapeutics Right Now
Key PointsCRISPR Therapeutics is still losing money, but it has an expanding pipeline...
Nasdaq News: Markets·6d ago
News Placeholder
Three Best Genomics Stocks for Your Portfolio in 2026
Genomics gains momentum as breakthroughs, falling sequencing costs, and CRISPR advances drive precision medicine and fuel rapid market growth.
Zacks·6d ago
News Placeholder
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks·11d ago
News Placeholder
Sutro Biopharma (STRO) Moves 7.4% Higher: Will This Strength Last?
Sutro Biopharma (STRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·11d ago
News Placeholder
CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $49.51, moving +1.43% from the previous trading session.
Zacks·17d ago
News Placeholder
CRISPR Therapeutics AG (CRSP) Exceeds Market Returns: Some Facts to Consider
In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $48.81, denoting a +2.61% move from the preceding trading day.
Zacks·18d ago
<
1
2
...
>

Latest CRSP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.